Delivering Revolutionary Cell/Gene Therapies to the Underserved, Creating More Accessibility
By David Jensen,
The California Stem Cell Report
| 04. 24. 2023
What good is a “miraculous” cure or a revolutionary therapy -- which is the goal of a $12 billion state of California enterprise -- if it is not accessible to patients?
That’s a question implicitly posed by a former member of the governing board of that enterprise, the California Institute for Regenerative Medicine (CIRM), more commonly known as the stem cell agency. And he had an answer to the question and a suggestion for the state program.
The remarks come from Jeff Sheehy, who served on the board for 16 years beginning in 2004, the year CIRM was created. He sent the California Stem Cell Report a note after the publication of an article about CIRM’s $80 million effort to create a public-private manufacturing network to overcome obstacles to the production of stem cell and related therapies.
Sheehy spoke to the lack of availability of advanced medical care in underserved areas of California, many of which are rural and remote from the centers where cell and genetic treatments can be done. He proposed that CIRM develop a “capacity...
Related Articles
By Mary Annette Pember, ICT News [cites CGS' Katie Hasson] | 04.18.2025
The sight of a room full of human cadavers can be off-putting for some, but not for Haley Omeasoo.
In fact, Omeasoo’s comfort level and lack of squeamishness convinced her to pursue studies in forensics and how DNA can be...
By Katrina Northrop, The Washington Post | 04.06.2025
photo via Wikimedia Commons licensed under CC by 3.0
China's most infamous scientist is attempting a comeback. He Jiankui, who went to jail for three years after claiming he had created the world's first genetically altered babies, says he remains...
By Anna Louie Sussman, The New York Times | 04.01.2025
When Noor Siddiqui was growing up, her mother developed retinitis pigmentosa, a condition that leads to gradual vision loss. When Ms. Siddiqui’s mother was in her 30s, she began going blind. Last summer, Ms. Siddiqui told a podcast host that...
By Lisa Eadicicco, CNN [cites CGS' Katie Hasson] | 03.30.2025
23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of its 15 million customers to wonder: What happens to my genetic data now...
